Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...
Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and ...
Clinical Trials Arena on MSN
Thermo Fisher to buy Clario for $8.8bn
The completion of the acquisition is anticipated by mid-2026, pending the satisfaction of customary closing conditions.
Stocktwits on MSN
Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal
In addition to the upfront payment of $8.875 billion, Thermo Fisher has agreed to $125 million in January 2027 and up to $400 ...
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback